Millennium Management LLC reduced its holdings in shares of Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 69.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,711 shares of the company's stock after selling 3,833 shares during the quarter. Millennium Management LLC's holdings in Hamilton Lane were worth $253,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors also recently bought and sold shares of HLNE. Vanguard Group Inc. grew its position in shares of Hamilton Lane by 28.4% during the fourth quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock worth $577,681,000 after purchasing an additional 863,326 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Hamilton Lane by 25.3% in the 4th quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock worth $284,738,000 after purchasing an additional 388,019 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of Hamilton Lane by 229.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock worth $191,321,000 after purchasing an additional 900,283 shares during the period. Geode Capital Management LLC lifted its stake in shares of Hamilton Lane by 4.1% during the 4th quarter. Geode Capital Management LLC now owns 1,149,928 shares of the company's stock worth $170,280,000 after acquiring an additional 44,865 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. lifted its stake in shares of Hamilton Lane by 10.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock worth $115,533,000 after acquiring an additional 70,976 shares during the last quarter. Institutional investors own 97.40% of the company's stock.
Hamilton Lane Stock Performance
NASDAQ HLNE traded down $7.54 on Friday, hitting $138.95. 791,536 shares of the company's stock were exchanged, compared to its average volume of 472,796. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.19 and a quick ratio of 4.19. The firm's 50-day moving average price is $153.55 and its two-hundred day moving average price is $154.85. Hamilton Lane Incorporated has a fifty-two week low of $114.85 and a fifty-two week high of $203.72. The firm has a market cap of $7.44 billion, a price-to-earnings ratio of 25.64 and a beta of 1.25.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last announced its quarterly earnings results on Thursday, May 29th. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.20 by $0.01. Hamilton Lane had a return on equity of 36.69% and a net margin of 31.12%. The business had revenue of $197.97 million for the quarter, compared to analyst estimates of $165.49 million. During the same quarter in the previous year, the company earned $1.38 EPS. The company's quarterly revenue was up 12.1% on a year-over-year basis. On average, research analysts expect that Hamilton Lane Incorporated will post 4.97 EPS for the current year.
Hamilton Lane Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Monday, July 7th. Investors of record on Friday, June 20th will be issued a $0.54 dividend. This is an increase from Hamilton Lane's previous quarterly dividend of $0.49. This represents a $2.16 annualized dividend and a yield of 1.55%. The ex-dividend date is Friday, June 20th. Hamilton Lane's dividend payout ratio is currently 40.07%.
Analyst Ratings Changes
Several research firms have recently commented on HLNE. Morgan Stanley reduced their price target on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research report on Monday, April 14th. Wall Street Zen lowered Hamilton Lane from a "hold" rating to a "sell" rating in a report on Friday, June 6th. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a report on Thursday, May 15th. Keefe, Bruyette & Woods lowered their price target on Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating on the stock in a research report on Monday, June 2nd. Finally, Wells Fargo & Company lowered their price target on Hamilton Lane from $166.00 to $161.00 and set an "equal weight" rating on the stock in a research report on Friday, May 30th. Two equities research analysts have rated the stock with a sell rating and six have issued a hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $164.29.
Check Out Our Latest Report on Hamilton Lane
Hamilton Lane Profile
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Recommended Stories

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.